AAPL308.91-24.52 (-7.35%) ▼|ABBV250.94-6.47 (-2.51%) ▼|ABT105.70+0.09 (+0.09%) ▲|ACN165.92+2.63 (+1.61%) ▲|ADBE250.41+2.51 (+1.01%) ▲|AMAT507.67+5.90 (+1.18%) ▲|AMD476.15-9.24 (-1.90%) ▼|AMGN385.16-2.48 (-0.64%) ▼|AMT173.36-1.10 (-0.63%) ▼|AMZN271.58+36.08 (+15.32%) ▲|AVGO389.28+1.44 (+0.37%) ▲|AXP336.25-1.27 (-0.38%) ▼|BA216.14-4.76 (-2.15%) ▼|BAC61.95+0.22 (+0.36%) ▲|BKNG192.90-0.34 (-0.18%) ▼|BLK1,090.39-7.98 (-0.73%) ▼|BMY65.31+0.45 (+0.69%) ▲|BNY156.33+0.25 (+0.16%) ▲|BRK-B511.54+1.86 (+0.36%) ▲|C132.45+0.13 (+0.10%) ▲|CAT814.81+5.67 (+0.70%) ▲|CL91.30-0.30 (-0.33%) ▼|CMCSA23.96+0.29 (+1.23%) ▲|COF209.01-1.13 (-0.54%) ▼|COP120.48+1.45 (+1.22%) ▲|COST951.89-2.28 (-0.24%) ▼|CRM184.02+3.31 (+1.83%) ▲|CSCO115.99+2.43 (+2.14%) ▲|CVS104.43-0.79 (-0.75%) ▼|CVX196.83+4.52 (+2.35%) ▲|DE592.67-6.80 (-1.13%) ▼|DHR194.98-1.19 (-0.61%) ▼|DIS96.19+0.03 (+0.03%) ▲|DUK125.43-0.84 (-0.67%) ▼|EMR149.82+1.18 (+0.79%) ▲|FDX307.40-1.15 (-0.37%) ▼|GD383.42+1.22 (+0.32%) ▲|GE360.07+5.03 (+1.42%) ▲|GEV990.29+8.31 (+0.85%) ▲|GILD130.21-1.07 (-0.82%) ▼|GM88.86+0.46 (+0.52%) ▲|GOOG356.65+22.97 (+6.88%) ▲|GOOGL356.13+22.47 (+6.73%) ▲|GS1,018.38-6.48 (-0.63%) ▼|HD331.96-1.39 (-0.42%) ▼|HON243.05+1.14 (+0.47%) ▲|IBM223.65+1.91 (+0.86%) ▲|INTC90.20-0.93 (-1.02%) ▼|INTU316.07+0.57 (+0.18%) ▲|ISRG353.33+0.36 (+0.10%) ▲|JNJ256.35+0.53 (+0.21%) ▲|JPM351.79+0.94 (+0.27%) ▲|KO87.59-0.90 (-1.02%) ▼|LIN478.38-30.26 (-5.95%) ▼|LLY1,148.84-6.13 (-0.53%) ▼|LMT582.74+8.63 (+1.50%) ▲|LOW207.81-2.27 (-1.08%) ▼|LRCX293.02-4.70 (-1.58%) ▼|MA573.10-4.25 (-0.74%) ▼|MCD270.64+2.20 (+0.82%) ▲|MDLZ62.31-0.77 (-1.22%) ▼|MDT85.39-0.32 (-0.37%) ▼|META556.71+17.68 (+3.28%) ▲|MMM176.28+0.21 (+0.12%) ▲|MO68.33+0.39 (+0.57%) ▲|MRK130.20+0.41 (+0.32%) ▲|MS210.42+1.51 (+0.72%) ▲|MSFT464.72+13.62 (+3.02%) ▲|MU823.03-51.63 (-5.90%) ▼|NEE86.92-1.01 (-1.15%) ▼|NFLX71.71-1.46 (-2.00%) ▼|NKE41.71-0.58 (-1.37%) ▼|NOW111.23+1.16 (+1.05%) ▲|NVDA200.75+5.71 (+2.93%) ▲|ORCL129.87+2.31 (+1.81%) ▲|PEP139.56-0.64 (-0.46%) ▼|PFE25.01+0.10 (+0.40%) ▲|PG144.49+0.53 (+0.37%) ▲|PLTR123.06+0.80 (+0.65%) ▲|PM190.82-1.18 (-0.61%) ▼|QCOM147.61-3.99 (-2.63%) ▼|RTX215.22+0.84 (+0.39%) ▲|SBUX105.25-0.60 (-0.57%) ▼|SCHW105.24+0.91 (+0.87%) ▲|SO94.54+0.20 (+0.21%) ▲|SPG229.37-1.07 (-0.46%) ▼|T23.25+0.04 (+0.17%) ▲|TMO574.30-2.47 (-0.43%) ▼|TMUS172.71-0.63 (-0.36%) ▼|TSLA311.21+2.36 (+0.76%) ▲|TXN275.74-3.02 (-1.08%) ▼|UBER70.36-0.01 (-0.01%) ▼|UNH414.40-7.07 (-1.68%) ▼|UNP292.13+2.67 (+0.92%) ▲|UPS104.22-1.05 (-1.00%) ▼|USB63.01+0.11 (+0.17%) ▲|V366.13-0.14 (-0.04%) ▼|VZ46.81+0.70 (+1.52%) ▲|WFC86.45+1.02 (+1.19%) ▲|WMT111.20+0.10 (+0.09%) ▲|XOM155.44-1.53 (-0.97%) ▼|AAPL308.91-24.52 (-7.35%) ▼|ABBV250.94-6.47 (-2.51%) ▼|ABT105.70+0.09 (+0.09%) ▲|ACN165.92+2.63 (+1.61%) ▲|ADBE250.41+2.51 (+1.01%) ▲|AMAT507.67+5.90 (+1.18%) ▲|AMD476.15-9.24 (-1.90%) ▼|AMGN385.16-2.48 (-0.64%) ▼|AMT173.36-1.10 (-0.63%) ▼|AMZN271.58+36.08 (+15.32%) ▲|AVGO389.28+1.44 (+0.37%) ▲|AXP336.25-1.27 (-0.38%) ▼|BA216.14-4.76 (-2.15%) ▼|BAC61.95+0.22 (+0.36%) ▲|BKNG192.90-0.34 (-0.18%) ▼|BLK1,090.39-7.98 (-0.73%) ▼|BMY65.31+0.45 (+0.69%) ▲|BNY156.33+0.25 (+0.16%) ▲|BRK-B511.54+1.86 (+0.36%) ▲|C132.45+0.13 (+0.10%) ▲|CAT814.81+5.67 (+0.70%) ▲|CL91.30-0.30 (-0.33%) ▼|CMCSA23.96+0.29 (+1.23%) ▲|COF209.01-1.13 (-0.54%) ▼|COP120.48+1.45 (+1.22%) ▲|COST951.89-2.28 (-0.24%) ▼|CRM184.02+3.31 (+1.83%) ▲|CSCO115.99+2.43 (+2.14%) ▲|CVS104.43-0.79 (-0.75%) ▼|CVX196.83+4.52 (+2.35%) ▲|DE592.67-6.80 (-1.13%) ▼|DHR194.98-1.19 (-0.61%) ▼|DIS96.19+0.03 (+0.03%) ▲|DUK125.43-0.84 (-0.67%) ▼|EMR149.82+1.18 (+0.79%) ▲|FDX307.40-1.15 (-0.37%) ▼|GD383.42+1.22 (+0.32%) ▲|GE360.07+5.03 (+1.42%) ▲|GEV990.29+8.31 (+0.85%) ▲|GILD130.21-1.07 (-0.82%) ▼|GM88.86+0.46 (+0.52%) ▲|GOOG356.65+22.97 (+6.88%) ▲|GOOGL356.13+22.47 (+6.73%) ▲|GS1,018.38-6.48 (-0.63%) ▼|HD331.96-1.39 (-0.42%) ▼|HON243.05+1.14 (+0.47%) ▲|IBM223.65+1.91 (+0.86%) ▲|INTC90.20-0.93 (-1.02%) ▼|INTU316.07+0.57 (+0.18%) ▲|ISRG353.33+0.36 (+0.10%) ▲|JNJ256.35+0.53 (+0.21%) ▲|JPM351.79+0.94 (+0.27%) ▲|KO87.59-0.90 (-1.02%) ▼|LIN478.38-30.26 (-5.95%) ▼|LLY1,148.84-6.13 (-0.53%) ▼|LMT582.74+8.63 (+1.50%) ▲|LOW207.81-2.27 (-1.08%) ▼|LRCX293.02-4.70 (-1.58%) ▼|MA573.10-4.25 (-0.74%) ▼|MCD270.64+2.20 (+0.82%) ▲|MDLZ62.31-0.77 (-1.22%) ▼|MDT85.39-0.32 (-0.37%) ▼|META556.71+17.68 (+3.28%) ▲|MMM176.28+0.21 (+0.12%) ▲|MO68.33+0.39 (+0.57%) ▲|MRK130.20+0.41 (+0.32%) ▲|MS210.42+1.51 (+0.72%) ▲|MSFT464.72+13.62 (+3.02%) ▲|MU823.03-51.63 (-5.90%) ▼|NEE86.92-1.01 (-1.15%) ▼|NFLX71.71-1.46 (-2.00%) ▼|NKE41.71-0.58 (-1.37%) ▼|NOW111.23+1.16 (+1.05%) ▲|NVDA200.75+5.71 (+2.93%) ▲|ORCL129.87+2.31 (+1.81%) ▲|PEP139.56-0.64 (-0.46%) ▼|PFE25.01+0.10 (+0.40%) ▲|PG144.49+0.53 (+0.37%) ▲|PLTR123.06+0.80 (+0.65%) ▲|PM190.82-1.18 (-0.61%) ▼|QCOM147.61-3.99 (-2.63%) ▼|RTX215.22+0.84 (+0.39%) ▲|SBUX105.25-0.60 (-0.57%) ▼|SCHW105.24+0.91 (+0.87%) ▲|SO94.54+0.20 (+0.21%) ▲|SPG229.37-1.07 (-0.46%) ▼|T23.25+0.04 (+0.17%) ▲|TMO574.30-2.47 (-0.43%) ▼|TMUS172.71-0.63 (-0.36%) ▼|TSLA311.21+2.36 (+0.76%) ▲|TXN275.74-3.02 (-1.08%) ▼|UBER70.36-0.01 (-0.01%) ▼|UNH414.40-7.07 (-1.68%) ▼|UNP292.13+2.67 (+0.92%) ▲|UPS104.22-1.05 (-1.00%) ▼|USB63.01+0.11 (+0.17%) ▲|V366.13-0.14 (-0.04%) ▼|VZ46.81+0.70 (+1.52%) ▲|WFC86.45+1.02 (+1.19%) ▲|WMT111.20+0.10 (+0.09%) ▲|XOM155.44-1.53 (-0.97%) ▼|
25.1 C
New York
Sunday, August 2, 2026

Tag: Jazz Pharmaceuticals

newssourceFORcompanyinformationcontent1releasesmarket

Questex’s DPHARM Announces Senior Leadership and Keynotes for the 16th Annual Conference

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- DPHARM, the leading innovation event for clinical trial operation executives, announces the 16th annual conference agenda including its senior leadership and keynotes. DPHARM which is now part of Questex’s Fierce Life Sciences, takes place September 15-16, 2026, at the Sheraton Boston Hotel.

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026

VANCOUVER, British Columbia, June 14, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today presented new clinical data from the dose-escalation portion of its ongoing Phase 1 study evaluating ZW191, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), at the European Society for Medical Oncology (ESMO) Gynaecological Cancers Congress 2026.

The Galien Foundation Announces 2025 Prix Galien USA Nominees for “Best Biotechnology Product,” “Best Pharmaceutical Product” and “Best Product for Rare/Orphan Diseases”

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the...

Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma

Modeyso is the first treatment option for this ultra-rare and aggressive brain tumor, which primarily affects children and young adults Accelerated approval based on an...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsJazz Pharmaceuticals

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers